Q2 2013 13F Holders as of 30 Jun 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
174,492
-
Share change
-
0
-
Total reported value
-
$1,363,000
-
Price per share
-
$7.81
-
Number of holders
-
3
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2013
As of 30 Jun 2013,
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
174,492 shares.
The largest 3 holders included
PDT Partners, LLC, WELLS FARGO & COMPANY/MN, and CITADEL ADVISORS LLC.
This page lists
3
institutional shareholders reporting positions in this security
for the Q2 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.